Hargreaves Lansdown chairperson Deanna Oppenheimer is stepping down after six years at the helm.
Oppenheimer is expected to stand down at the next annual general meeting on December 8.
She is set to be replaced by Alison Platt, subject to regulatory approval, early next year.
In the meantime, Penny James, currently the senior independent director, will take on the role of interim chairperson. She will also chair the AGM.
Platt is currently chairperson of Dechra Pharmaceuticals, a specialist veterinary products business and is also a non-executive director of Tesco plc and the chairperson of general insurer, Ageas UK.
She was chairperson of L&G Financial Advice from 2019 to 2022 and CEO of Countrywide from 2014 to 2018. Prior to that she held several senior roles at BUPA, both in the UK and Internationally.
"I am delighted to be joining the HL Board and excited by the opportunity to work with the team as HL continues its critical work in supporting clients to make savings and investment decisions with confidence. I look forward to working closely with my new board colleagues to guide HL's next phase of growth," said Platt
Hargreaves Lansdown confirmed in a regulatory note that a motion to re-elect Oppenheimer as chairperson has now been withdrawn from the December 8 agenda.
Oppenheimer said: "I'm honoured to have overseen the board during a period of significant change for the industry and for HL.
"HL is in a strong position for growth and has skilled leadership which will ensure the company's future success. Over the last six years our client numbers have doubled to 1.8nb and our share of the direct-to-consumer market has grown significantly from 35 to 42 per cent."
tara.o'connor@ft.com
What's your view?
Have your say in the comments section below or email us: ftadviser.newsdesk@ft.com
